Smartphone program to help with thinking in psychotic disorders
Part of Mental health clinical trials.
This trial tests a smartphone-based program designed to help people with psychotic disorders improve their thinking and stay motivated. It may help you if you struggle with memory, focus, or decision-making.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of schizophrenia, schizoaffective disorder, or a related psychotic disorder
- You own a smartphone
- You speak English
- You have some problems with thinking, memory, or focus
- Your antipsychotic medication has not changed in the past month
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment approach using a smartphone app designed to help with negative symptoms of schizophrenia, like low motivation or emotional flatness. It aims to see if the app is helpful and safe for people who are stable in their treatment.
This study tests a mobile app designed to help with thinking and memory for people with schizophrenia or those at high risk for psychosis. It aims to see if the app is easy to use and if it improves cognitive function.
This trial tests a smartphone app designed to help people with schizophrenia or schizoaffective disorder improve their social thinking and interactions. It may be a good option if you can use an app and are on stable medication.
This study tests a smartphone app that tracks your mood and offers personalized tips or exercises to help manage depression or anxiety. It aims to see if this approach can improve your emotional well-being.
This trial tests a smartphone-based program designed to help people who have frequent suicidal thoughts. It aims to provide support through your phone, so you can get help when you need it.
This study tests a smartphone-based program to help people with schizophrenia manage their health and reduce early death risks like high blood pressure or diabetes. It aims to make care more accessible in primary care settings in India.
Hear when a new Schizophrenia / Schizoaffective Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.